158 related articles for article (PubMed ID: 18337576)
1. Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.
Bowen DG; Shoukry NH; Grakoui A; Fuller MJ; Cawthon AG; Dong C; Hasselschwert DL; Brasky KM; Freeman GJ; Seth NP; Wucherpfennig KW; Houghton M; Walker CM
J Virol; 2008 May; 82(10):5109-14. PubMed ID: 18337576
[TBL] [Abstract][Full Text] [Related]
2. Signatures of protective memory immune responses during hepatitis C virus reinfection.
Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
[TBL] [Abstract][Full Text] [Related]
3. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
Shoukry NH; Grakoui A; Houghton M; Chien DY; Ghrayeb J; Reimann KA; Walker CM
J Exp Med; 2003 Jun; 197(12):1645-55. PubMed ID: 12810686
[TBL] [Abstract][Full Text] [Related]
4. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
5. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
[TBL] [Abstract][Full Text] [Related]
6. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
7. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.
Urbani S; Amadei B; Tola D; Massari M; Schivazappa S; Missale G; Ferrari C
J Virol; 2006 Nov; 80(22):11398-403. PubMed ID: 16956940
[TBL] [Abstract][Full Text] [Related]
8. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
9. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Callendret B; Eccleston HB; Hall S; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2014 Nov; 60(5):1531-40. PubMed ID: 24975498
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
Fuller MJ; Callendret B; Zhu B; Freeman GJ; Hasselschwert DL; Satterfield W; Sharpe AH; Dustin LB; Rice CM; Grakoui A; Ahmed R; Walker CM
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15001-6. PubMed ID: 23980172
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
14. HCV persistence and immune evasion in the absence of memory T cell help.
Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM
Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438
[TBL] [Abstract][Full Text] [Related]
15. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
[TBL] [Abstract][Full Text] [Related]
16. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
Lukens JR; Cruise MW; Lassen MG; Hahn YS
J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
[TBL] [Abstract][Full Text] [Related]
17. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
18. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man.
Bowen DG; Walker CM
J Exp Med; 2005 Jun; 201(11):1709-14. PubMed ID: 15939787
[TBL] [Abstract][Full Text] [Related]
19. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
Radziewicz H; Ibegbu CC; Hon H; Osborn MK; Obideen K; Wehbi M; Freeman GJ; Lennox JL; Workowski KA; Hanson HL; Grakoui A
J Virol; 2008 Oct; 82(20):9808-22. PubMed ID: 18667503
[TBL] [Abstract][Full Text] [Related]
20. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo.
Seigel B; Bengsch B; Lohmann V; Bartenschlager R; Blum HE; Thimme R
Gastroenterology; 2013 Feb; 144(2):426-436. PubMed ID: 23142136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
